drugset / Trial / NCT06453603

Efficacy of Platelet-rich Plasma Injection Compare With Corticosteroid in Pes Anserinus Pain Syndrome

NCT06453603

Not yet recruiting 24 enrolled Ramathibodi Hospital
RandomizedParallel-groupTriple-blindTreatment

Summary

The goal of this research is to study the efficacy of treatment between PRP injection and corticosteroid injection in patients with pes anserinus bursitis. The research question is whether PRP can reduce pain more effectively than corticosteroids. The study is divided into two groups: one group receiving PRP injections and the second group receiving corticosteroid injections. Treatment outcomes will be monitored at four time points: baseline, 4 weeks, 12 weeks, and 24 weeks. The outcomes will be measured using the VAS and WOMAC scores.

Timeline

Start
2024-07-01
Primary completion
2026-12-31
Completion
2026-12-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject PRP Unknown 4 ml
Comparator Triamcinolone Acetonide Other / unclassified 40 mg
Comparator Lidocaine Other / unclassified 3 ml